SCHEMBL20053869

SCHEMBL20053869

Fc1cc2c(cc1Nc1ncc(C(F)(F)F)cn1)CCN1CCNCC21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17552262 1.00
Hydrochloric Acid SCHEMBL18863219 0.99
SCHEMBL20053846 0.84
SCHEMBL17552261 0.84
SCHEMBL18863198 0.81 MDM2 (0.35)
SCHEMBL17552247 0.72
SCHEMBL18863140 0.72
SCHEMBL18863252 0.72
Hydrochloric Acid SCHEMBL18863225 0.71
SCHEMBL18863130 0.69 JAK2 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3186250-B1 SUBSTITUTED PYRAZINO[2,1-A]ISOQUINOLINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2018-04-18 EP disclosed